European Commission Explains Impact Of Brexit On Clinical Trials
Executive Summary
The European Commission has outlined various aspects of the clinical trial process that may be affected after the UK withdraws from the EU, and explains how sponsors should prepare.
You may also be interested in...
EMA Consults On Using Registry Studies As RWE Source
A draft EU guideline explains how disease registries can be used to supplement evidence in the pre-authorization phase and provide infrastructure for post-authorization evidence generation.
EMA Has Work Cut Out Before New Clinical Trial Portal Goes Live
Companies are being encouraged to become “early adopters” of the EU Clinical Trials Information System when it goes live in December 2021.
EMA Explains Dos And Don’ts Of New Clinical Trials Portal
Drug companies will be able to “play around” with the new EU Clinical Trials Information System in a secure testing environment before it goes live in approximately 15 months.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: